Home > News > The Impact of Exercise on DNA Methylation of Genes Associated with Type 2 Diabetes and Obesity in Human Adipose Tissue
Obesity
Read Time: 6 mins

The Impact of Exercise on DNA Methylation of Genes Associated with Type 2 Diabetes and Obesity in Human Adipose Tissue

Published Online: June 9th 2014 US Endocrinology, 2014;10(1):64–6 DOI: http://doi.org/10.17925/USE.2014.10.01.64
Authors: Tina R, Charlotte Ling
Quick Links:
Abstract
Article
Article Information
Abstract:
Overview

It is well established that exercise promotes health, and reduces people’s risks for developing type 2 diabetes and becoming obese. But just how exercise performs this, at a cellular level, and what molecular and physiologic steps are involved and in what order, are still not fully understood. Metabolic disorders are often influenced by interactions between genetic and environmental factors. One possible explanation for how the environment may influence the genome is through epigenetic mechanisms–that is–chemical modifications to the DNA itself. Epigenetic factors include, for example, DNA methylation, histone modifications, and different RNA-mediated processes, which all have the ability to bind to DNA or affect the chromatin structure and thereby change how specific genes are interpreted and expressed. In this short review, we focus on describing how exercise influences the genome-wide DNA methylation pattern, including candidate genes for obesity and type 2 diabetes, in human adipose tissue.

Keywords

Epigenetics, DNA methylation, messenger RNA (mRNA) expression, exercise, adipose tissue, skeletal muscle, obesity, type 2 diabetes

Article:

Epigenetics, Gene Regulation, and Human Diseases

Epigenetics, Gene Regulation, and Human Diseases
Genes are not static and may be turned on or off, depending on what signals they receive from elsewhere in the body or from the surrounding environment. When they are turned on, genes express various proteins that, in turn, start a range of physiologic actions in the body. One way of affecting gene activity involves a process called DNA methylation, in which methyl groups, a cluster of carbon and hydrogen atoms, attach to certain nucleotides of a gene and make it easier or harder for that gene to receive and respond to messages from the body. In this way, the behavior of the gene is changed, but not the fundamental structure of the gene, or the DNA sequence, itself. This phenomenon is known as epigenetics and, remarkably, these DNA methylation patterns can be passed on to and inherited by new cells or even offspring.1 Epigenetic mechanisms are now implicated in gene regulation and the development of different diseases.2,3 What is fascinating about the epigenetic processes is that although mainly established early in life, it seems to be possible to affect it throughout life,4–7 suggestively through, for example, exercise, diet, and lifestyle.3

DNA Methylation in Human Adipose Tissue
The epigenome differs between cell types and has only been characterized for a limited number of human tissues. As obesity predicts type 2 diabetes, adipose tissue seems likely to also have a role in the disease development.8 Indeed, recent studies suggest adipose tissue DNA methylation to have a role in metabolic disturbances. For example, DNA methylation in the promoter of ADRB3 in visceral adipose tissue has been associated with waist-to-hip ratio and blood pressure in obese men.9 Also, the metabolic regulator PPARGC1A exhibit altered DNA methylation levels in subcutaneous adipose tissue after high-fat overfeeding in a birth weight dependent manner.10 This adds to the dynamic epigenetic regulation of this gene and the association with metabolic phenotypes, which has previously also been demonstrated in human skeletal muscle11,12 and pancreatic islets.13 PPARGC1A encodes the transcriptional co-activator peroxisome proliferator-activated receptor gamma (PPAR-g) coactivator-1a, which is known to regulate the expression of genes with a central role in mitochondria and it also plays a major role in adipose tissue.14–16 Another study identified 3,258 genes differentially methylated in visceral adipose tissue in obese individuals with or without the metabolic syndrome, translated into 41 pathways, pointing at structural components of the cell membrane, inflammation, and immunity, and cell cycle regulation to be important.17 The most comprehensive genome-wide DNA methylation study so far, considering adipose tissue, showed evidence of hypomethylated regions in tissue-specific regulatory elements that play a critical role in gene regulation and susceptibility to metabolic diseases.18 This was exemplified by an association of metabolic disease and altered DNA methylation in an enhancer element upstream of ADCY3, a region previously linked to metabolic diseases and processes. The strong tissue specificity of DNA methylation has also been shown within different adipose depots, with the ability to epigenetically regulate depot-specific gene expression in abdominal and gluteal adipose tissue.19 This is an important finding considering that different adipose depots are known to mediate different effects on the risk for metabolic disorders.

Multiple studies in human pancreatic islets as well as skeletal muscle suggest an epigenetic component in the regulation of genes involved in the pathogenesis of type 2 diabetes and glucose metabolism.5,6.20–23 However, the role of DNA methylation, and involvement of physical activity, on different genes in subcutaneous adipose tissue has until recently been poorly understood.

Genome-wide Changes in DNA Methylation in Response to Exercise
In a recent study, we investigated the genome-wide DNA methylation pattern in human adipose tissue biopsies before versus after a 6-month exercise intervention.24 The study cohort included middle aged, previously sedentary men. Surprisingly, we could see that changes in the DNA methylation pattern in adipose tissue had taken place on almost 18,000 individual CpG sites throughout the genome after the exercise intervention, corresponding to 7,663 unique genes or roughly 1/3 of all genes in the human genome. However, the absolute changes in DNA methylation were generally small, ranging from 0.2–10.9 % with a peak around 2–5 %. In most cases, the genes had become more methylated and about 90 % of the individual CpG sites that significantly changed in response to exercise increased the level of DNA methylation. Additionally, 1/3 of the gene regions with altered adipose tissue DNA methylation also showed a difference in the expression of that gene.

A similar approach has also been undertaken in human skeletal muscle using a different methodology.25 Here, 2,817 genes were found to be differentially methylated after the 6-month exercise intervention, but in contrast to what was found in adipose tissue, most of the genes showed decreased levels of DNA methylation after exercise. A pathway analysis revealed decreased DNA methylation of genes involved in retinol metabolism and calcium signaling as most significant after exercise. The insulin signaling pathway was enriched for genes exhibiting both increased and decreased DNA methylation.

Altered DNA Methylation of Genes Associated with Type 2 Diabetes and Obesity After Exercise Lifestyle interventions, including exercise and diet, are known to reduce the risk for type 2 diabetes in high-risk groups.26,27 One hypothesis in our study24 was therefore that altered adipose tissue DNA methylation as a result of physical activity could be one of the mechanisms of how selected candidate genes may affect the risk for metabolic diseases. Based on that, we investigated if candidate genes for obesity or type 2 diabetes, identified using genome-wide association studies,28 were found among the genes exhibiting changed levels of DNA methylation in adipose tissue in response to 6 months exercise. Among all 476,753 analyzed DNA methylation sites, 1,351 sites mapped to the 53 genes suggested to contribute to obesity, and 1,315 sites mapped to the 39 genes suggested to contribute to type 2 diabetes.

Indeed, we found 24 CpG sites located within 18 of the candidate genes for obesity with a significant difference in DNA methylation in adipose tissue in response to the exercise intervention (see Figure 1). Two of those genes (CPEB4 and SDCCAG8) also showed concurrent inverse change in messenger RNA (mRNA) expression after exercise. Among the type 2 diabetes candidate genes, 45 CpG sites in 21 different genes were differentially methylated in adipose tissue before versus after exercise (see Figure 1). Of note, 10 of these CpG sites mapped to KCNQ1, a gene known to undergo parental imprinting and encoding a potassium channel,29 and six CpG sites mapped to TCF7L2, the number one risk gene for type 2 diabetes. For both KCNQ1 and TCF7L2, all differentially methylated sites are found within the gene body, which is of particular interest since TCF7L2 encodes different splice variants30,31 and different methylation profiles between exons and introns may affect alternative splicing.32 Among the type 2 diabetes candidate genes with altered DNA methylation, a simultaneous change in mRNA expression was seen for HHEX, IGF2BP2, JAZF1 and TCF7L2, where mRNA expression decreased while DNA methylation increased in response to exercise.

Although the average difference in DNA methylation in response to exercise is of modest magnitude, the changes are often consistent across most individuals. This is, for example, seen for a methylation site in the gene body of ITPR2, where all individuals responded to exercise with an increase in DNA methylation. The ITPR2 locus has previously reported to be associated with waist–hip ratio.33 We found two methylation sites within this gene with altered DNA methylation in adipose tissue in response to exercise: one site located in the promoter region; one within the gene body. Interestingly, the men in the intervention also responded with a decrease in waist–hip ratio.

Also in skeletal muscle, exercise seems to affect the DNA methylation pattern of genes implicated in the pathogenesis of type 2 diabetes. For example, THADA and RBMS1 were differentially methylated in muscle in response to exercise in the study by Nitert et al.,25 as was MEF2A, a gene involved in the regulation of GLUT4 transcription.34 This study also investigated the impact of a genetic predisposition for type 2 diabeteson skeletal muscle DNA methylation and identified biological pathways including MAPK, insulin, and calcium signaling to be enriched for differentially methylated genes.25

Changes in DNA Methylation Induced by Exercise may Affect Adipocyte Metabolism Both HDAC4 and NCOR2 displayed increased DNA methylation and decreased mRNA expression in adipose tissue in response to exercise,24 and they are, for example, based on their capacity to regulate oxidative phosphorylation and GLUT4 expression, biologically interesting candidates in adipose tissue and the pathogenesis of obesity and type 2 diabetes.35,36 Furthermore, we found that HDAC4 had seven CpG sites within the gene body with an absolute difference in DNA methylation ranging from 5–8 % in response to exercise. Our functional studies where Hdac4 and Ncor2, respectively, were silenced in 3T3-L1 adipocytes resulted in 74 % reduction in the Hdac4 protein level and 56 % reduction in the Ncor2 mRNA level, accompanied by increased lipogenesis.24 These results suggest a link between DNA methylation, mRNA expression, and adipocyte metabolism, and could mean that regular exercise makes the adipocytes better in clearing the blood from glucose and lipids.

Conclusion
We recently described for the first time what happens on an epigenetic level in adipose tissue when we undertake physical activity and it is now evident that regular exercise can change the expression of our innate DNA through epigenetic mechanisms. The changes in DNA methylation in human adipose tissue in response to long-term exercise have a genome-wide range, but are also evident on the level of individual DNA methylation sites and genes. Interestingly, one-third of the differentially methylated CpG sites within gene regions also show a connection to altered gene expression of that gene.

Our results also suggest new mechanisms for how different genes may predispose to obesity or type 2 diabetes, and also a new mechanism for the beneficial effect of exercise on metabolic health. To account for cross-talk between tissues and the interplay within the whole human body, future studies should emphasize on investigating multiple tissues at different time points and in response to different external stimuli, to get a better understanding of the regulatory role of DNA methylation in the ever-changing environment. Additionally, it will be interesting to test if the epigenetic changes induced by exercise remain also when no or less exercise is performed, and if the epigenetic changes are reversible.

Article Information:
Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Tina Rönn, PhD, Department of Clinical Sciences, Malmö, Epigenetics and Diabetes Unit, Lund University Diabetes Centre, CRC, Building 91, Level 12, Jan Waldenströms Gata 35, 205 02 Malmö, Sweden. E: tina.ronn@med.lu.se
An erratum to this article can be found below.

Received

2014-05-02T00:00:00

References

  1. Bird A, DNA methylation patterns and epigenetic memory, Genes Dev, 2002;16:6–21.
  2. Gluckman PD, Hanson MA, Buklijas T, et al., Epigenetic mechanisms that underpin metabolic and cardiovascular diseases, Nat Rev Endocrinol, 2009;5:401–8.
  3. Ling C, Groop L, Epigenetics: a molecular link between environmental factors and type 2 diabetes, Diabetes, 2009;58:2718–25.
  4. Fraga MF, Ballestar E, Paz MF, et al., Epigenetic differences arise during the lifetime of monozygotic twins, Proc Natl Acad Sci U S A, 2005;102:10604–9.
  5. Ling C, Poulsen P, Simonsson S, et al., Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle, J Clin Invest, 2007;117:3427–35.
  6. Rönn T, Poulsen P, Hansson O, et al., Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle, Diabetologia, 2008;51:1159–68.
  7. Sandovici I, Smith NH, Nitert MD, et al., Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets, Proc Natl Acad Sci U S A, 2011;108:5449–54.
  8. Ronti T, Lupattelli G, Mannarino E, The endocrine function of adipose tissue: an update, Clin Endocrinol (Oxf), 2006;64:355–65.
  9. Guay SP, Brisson D, Lamarche B, et al., ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men, Epigenomics, 2014;6:33–43.
  10. Gillberg L, Jacobsen SC, Rönn T, et al., PPARGC1A DNA methylation in subcutaneous adipose tissue in low birth weight subjects--impact of 5 days of high-fat overfeeding, Metabolism, 2014;63:263–71.
  11. Brøns C, Jacobsen S, Nilsson E, et al., Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weightdependent manner, J Clin Endocrinol Metab, 2010;95:3048–56.
  12. Gillberg L, Jacobsen S, Ribel-Madsen R, et al., Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?, PLoS One, 2013;8:e58384.
  13. Ling C, Del Guerra S, Lupi R, et al., Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion, Diabetologia, 2008;51:615–22.
  14. Ling C, Poulsen P, Carlsson E, et al., Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC- 1beta gene expression in twins, J Clin Invest, 2004;114:1518-26.
  15. Puigserver P, Spiegelman BM, Peroxisome proliferatoractivated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator, Endocr Rev, 2003;24:78-90.
  16. Puigserver P, Wu Z, Park CW, et al., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 1998;92:829–39.
  17. Guénard F, Tchernof A, Deshaies Y, et al., Differential methylation in visceral adipose tissue of obese men discordant for metabolic disturbances, Physiol Genomics, 2014;46:216–22.
  18. Grundberg E, Meduri E, Sandling JK, et al., Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements, Am J Hum Genet, 2013;93:876–90.
  19. Gehrke S, Brueckner B, Schepky A, et al., Epigenetic regulation of depot-specific gene expression in adipose tissue, PLoS One, 2013;8:e82516.
  20. Barrès R, Osler ME, Yan J, et al., Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density, Cell Metab, 2009;10:189–98.
  21. Dayeh T, Volkov P, Salö S, et al., Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion, PLoS Genet, 2014;10:e1004160.
  22. Yang BT, Dayeh TA, Kirkpatrick CL, et al., Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets, Diabetologia, 2011;54:360–7.
  23. Yang BT, Dayeh TA, Volkov PA, et al., Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes, Mol Endocrinol, 2012; 26:1203–12.
  24. Rönn T, Volkov P, Davegårdh C, et al., A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue, PLoS Genet, 2013;9:e1003572.
  25. Nitert MD, Dayeh T, Volkov P, et al., Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes, Diabetes, 2012;61:3322–32.
  26. Knowler WC, Barrett-Connor E, Fowler SE, et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 2002;346:393–403.
  27. Tuomilehto J, Lindström J, Eriksson JG, et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 2001;344:1343–50.
  28. McCarthy MI, Genomics, type 2 diabetes, and obesity, N Engl J Med, 2010;363:2339–50.
  29. Travers ME, Mackay DJ, Dekker Nitert M, et al., Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets, Diabetes, 2013;62:987–92.
  30. Kaminska D, Kuulasmaa T, Venesmaa S, et al., Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism, Diabetes, 2012;61:2807–13.
  31. Osmark P, Hansson O, Jonsson A, et al., Unique splicing pattern of the TCF7L2 gene in human pancreatic islets, Diabetologia, 2009;52:850–4.
  32. Laurent L, Wong E, Li G, et al., Dynamic changes in the human methylome during differentiation, Genome Res, 2010;20:320–31.
  33. Heid IM, Jackson AU, Randall JC, et al., Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution, Nat Genet, 2010;42:949–60.
  34. McGee SL, Sparling D, Olson AL, Hargreaves M, Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle, FASEB J, 2006;20:348–9.
  35. Fang S, Suh JM, Atkins AR, et al., Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance, Proc Natl Acad Sci U S A, 2011;108:3412–7.
  36. Weems JC, Griesel BA, Olson AL, Class II histone deacetylases downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice, Diabetes, 2012;61:1404–14.

Further Resources

Share this Article
Related Content In Obesity
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72